Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A

Haemophilia

Volumn 19, Issue 5, 2013, Pages 720-726

  Nance, D ^a   Fletcher, S N ^a   Bolgiano, D C ^a   Thompson, A R ^a,b   Josephson, N C ^a,b   Konkle, B A ^a,b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

DDAVP; Factor VIII deficiency; Genotype; Haemophilia A; Mutation analysis; Treatment

Indexed keywords

DESMOPRESSIN;

ADOLESCENT; ARTICLE; BLOOD CLOTTING FACTOR 8 GENE; CHILD; GENE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HEMOPHILIA A; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

DDAVP; FACTOR VIII DEFICIENCY; GENOTYPE; HAEMOPHILIA A; MUTATION ANALYSIS; TREATMENT;

DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; HEMOPHILIA A; HUMANS; MUTATION; RETROSPECTIVE STUDIES;

EID: 84883052073     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12173     Document Type: Article

References (22)

1. Castaman G. Desmopressin for the treatment of haemophilia. Haemophilia 2008; 14(Suppl 1): 15-20.
2. Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild hemophilia A. Blood Coagul Fibrinolysis 2010; 21: 615-9.
3. Nolan B, White B, Smith J, O'Reily C, Fitzpatrick B, Smith OP. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders. Br J Haematol 2000; 109: 865-9.
4. Seary ME, Feldman D, Carcao MD. DDAVP responsiveness in children with mild or moderate haemophilia A correlates with age, endogenous FVIII:C level and with haemophilic genotype. Haemophilia 2012; 18: 50-5.
5. Ludlam CA, Peake IR, Allen N, Davies BL, Furlong RA, Bloom AL. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease. Br J Haematol 1980; 45: 499-511.
6. Castaman G, Mancuso ME, Giacomelli SH et al. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A. J Thromb Haemost 2009; 7: 1824-31.
7. Liu ML, Shen BW, Nakaya S et al. Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure. Blood 2000; 96: 979-87.
8. Liu ML, Nakaya S, Thompson AR. Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses. Thromb Haemost 2002; 87: 273-6.
9. Thompson AR. Structure and function of the factor VIII gene and protein. Semin Thromb Hemost 2003; 29: 11-22.
10. Markoff A, Gerke V, Bogdanova N. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia 2009; 15: 932-41.
11. Bogdanova N, Markoff A, Eisert R et al. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat 2007; 28: 54-60.
12. d'Oiron R, Pipe SW, Jacquemin M. Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development. Haemophilia 2008; 14 Suppl 3: 138-46.
13. Shen BW, Spiegel PC, Chang CH et al. The tertiary structure and domain organization of coagulation factor VIII. Blood 2008; 111: 1240-7.
14. Yue P, Li Z, Moult J. Loss of protein structure stability as a major causative factor in monogenic disease. J Mol Biol 2005; 353: 459-73.
15. Ngo JC, Huang M, Roth DA, Furie BC, Furie B. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure 2008; 16: 597-606.
16. Tagliaferri A, C DIP, Riccardi F, Pattacini C, Rivolta GF, Franchini M. The natural history of mild haemophilia: a 30-year single centre experience. Haemophilia 2012; 18: 166-74 [Epub ahead of print].
17. Franchini M, Favaloro EJ, Lippi G. Mild hemophilia A. J Thromb Haemost 2010; 8: 421-32.
18. Peerlinck K, Jacquemin M. Mild haemophilia: a disease with many faces and many unexpected pitfalls. Haemophilia 2010; 16(Suppl 5): 100-6.
19. Stoof SC, Sanders YV, Petrij F et al. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A. Thromb Haemost 2013; 109: 440-9.
20. Lui ML, Murphy MEP, Thompson AR. A domain mutations in 65 haemophilia A families and molecular modeling of dysfunctional factor VIII proteins. Br J Haem 1998; 103: 1051-60.
21. Lui ML, Thompson AR. Non-inversion factor VIII mutations in 80 haemophilia A families including 24 with alloimmune responses. Thromb Haemost 2002; 87: 273-6.
22. Goodeve AC, Reitsma PH, McVey JH, On Behalf of the Working Group on Nomenclature of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Nomenclature of genetic variants in hemostasis. J Thromb Haemost 2011; 9: 852-5.